Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities
- PMID: 26762799
- DOI: 10.1002/cmdc.201500498
Broadly Neutralizing Antibody-Guided Carbohydrate-Based HIV Vaccine Design: Challenges and Opportunities
Abstract
The HIV envelope (Env) is heavily glycosylated, facilitating the spread and survival of HIV in many ways. Some potent broadly neutralizing antibodies (bnAbs) such as 2G12, PG9, PG16, and PGTs can recognize the conserved glycan residues on Env. The bnAbs, which often emerge after many years of chronic infection, provide insight into the vulnerability of HIV and can therefore guide the design of vaccines. Many carbohydrate-conjugated vaccines have been designed to induce bnAb-like antibodies, but none have yet been successful. The low antigenicity of these vaccines is one possible explanation. New strategies have been applied to obtain high-affinity antigens of glycan-dependent and other bnAbs. However, when used as immunogens in vivo, high-affinity antigens are still insufficient in eliciting bnAb-like antibodies. bnAbs generally possess some unusual features and may therefore be suppressed by the host immune system. In view of this situation, some immunization regimens based on the affinity maturation of antibodies have been tested. Herein we summarize recent studies into the design of carbohydrate-based HIV vaccines and some valuable experiences gained in work with other bnAb-based HIV vaccines.
Keywords: antibodies; antiviral agents; carbohydrates; glycoconjugates; immunology.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.Expert Rev Vaccines. 2016;15(3):349-65. doi: 10.1586/14760584.2016.1129905. Epub 2016 Jan 8. Expert Rev Vaccines. 2016. PMID: 26654478 Review.
-
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25831. doi: 10.1002/jia2.25831. J Int AIDS Soc. 2021. PMID: 34806332 Free PMC article. Review.
-
Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen.ACS Chem Biol. 2016 Jun 17;11(6):1702-9. doi: 10.1021/acschembio.6b00224. Epub 2016 Apr 18. ACS Chem Biol. 2016. PMID: 27088577
-
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.AIDS Res Ther. 2017 Sep 12;14(1):50. doi: 10.1186/s12981-017-0178-3. AIDS Res Ther. 2017. PMID: 28893278 Free PMC article. Review.
-
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Retrovirology. 2018 Jul 28;15(1):52. doi: 10.1186/s12977-018-0433-2. Retrovirology. 2018. PMID: 30055627 Free PMC article. Review.
Cited by
-
Synthesis of Mannosidase-Stable Man3 and Man4 Glycans Containing S-linked Manα1→2Man Termini.Org Lett. 2021 Apr 16;23(8):3053-3057. doi: 10.1021/acs.orglett.1c00726. Epub 2021 Apr 1. Org Lett. 2021. PMID: 33793242 Free PMC article.
-
Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent.Pathogens. 2024 Mar 23;13(4):272. doi: 10.3390/pathogens13040272. Pathogens. 2024. PMID: 38668227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical